Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection: a prospective multicentre studyJordi Almirall, al et, R Priu et al.|European Respiratory Journal|1993Cited by 178
Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)Tobias Welte, Antoní Torres, R. Phillip Dellinger et al.|Intensive Care Medicine|2018Cited by 136